Celeste Krewson, Assistant Editor

A recent study reveals a significant association between accelerated biological aging and preterm birth, highlighting the need for further research into this potential risk factor.

Utilizing magnetic resonance imaging and ultrasound models to predict fetal weight in primigravid women can significantly reduce macrosomia-related adverse outcomes, with MRI showing superior accuracy.

A recent study reports that ring expulsions are infrequent and unrelated to body mass index or parity, with satisfaction rates remaining high among users.

A recent study reveals that adolescents with autism and other developmental disabilities have fewer visits to obstetrician-gynecologists and lower hormonal contraceptive use compared to their typically developing peers, highlighting a need for improved reproductive health services.

A recent study reveals similar overall reintervention risks between a 52-mg levonorgestrel-releasing intrauterine system and radiofrequency endometrial ablation for treating heavy menstrual bleeding.

A recent study reveals no significant association between COVID-19 vaccination and the incidence of abnormal uterine bleeding among reproductive-aged women.

Review some of the top stories from Contemporary OB/GYN's coverage of ACOG 2024, and catch up on anything you may have missed.

A new study highlights significant levels of harassment in obstetrics and gynecology, emphasizing the urgent need for effective interventions.

Mary Claire B. Manske, MD, discusses her findings on the unexplained increased risk of brachial plexus birth injury among Black and Hispanic infants, highlighting the need for improved prenatal care and further research.

Experts discuss the necessity of evolving prenatal care through innovative models to better meet patient needs and incorporate advances such as telemedicine.

Dive into the research presented by Rhonda R. Voskuhl at ACOG 2024, shedding light on the potential of estrogen receptor beta as a target to mitigate cognitive decline in postmenopausal women.

At ACOG 2024, Monica M. Christmas, MD, FACOG, and Stephanie Faubion, MD, emphasize the importance of combating disinformation in menopause care and provide clinicians with evidence-based strategies to manage symptoms effectively.

At the 2024 ACOG Annual Clinical & Scientific Meeting, experts emphasized the importance of equipping ob-gyns with the knowledge and tools to address sexual health issues, including hyperactive sexual desire disorder, anorgasmia, and pelvic pain.

Phase 3 data presented by JoAnn Pinkerton, MD, reveals that elinzanetant significantly improves hot flash frequency, sleep, and overall menopause quality of life, offering a promising alternative to estrogen therapy.

A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.

Leanne R. McCloskey, MD, and Weronika A. Armstrong, MD, xplore the multifaceted applications of misoprostol in obstetrics, covering protocols, safety, and the impact on birth equity from early pregnancy loss to labor induction at ACOG 2024.

A recent study suggests that higher CASP8 expression in embryos is associated with successful implantation outcomes in women of advanced maternal age, as presented at ACOG 2024.

Michelle Jacobson, MD, MHSc, FRCSC, shares critical perspectives on managing vasomotor symptoms in breast cancer patients at the recent ACOG Annual Clinical & Scientific Meeting, emphasizing the importance of tailored approaches amidst evolving treatment options and patient risks.

A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.

A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.

Roche's innovative human papillomavirus self-collection solution offers a breakthrough in cervical cancer screening, providing accessible and reliable testing to combat underscreening rates and increase early detection.

A study highlights how having a primary care physician significantly increases the likelihood of cervical cancer screening among lesbian, gay, and bisexual cisgender women, addressing disparities exacerbated by systemic discrimination and healthcare access challenges.

A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.

Discover how recent findings highlight the significance of echogenic masses in accurately diagnosing post-pregnancy complications, shedding light on effective management strategies and reducing the need for invasive interventions.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

A recent study revealed that mail-order pharmacy dispensing of mifepristone for medication abortion proves effective and satisfactory, highlighting a potential avenue for expanding access to reproductive healthcare.

A recent study reveals associations between concomitant histological fetal inflammatory response and adverse neonatal outcomes, urging further investigation into implications.

Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.

Elina Melik-Levine, ARNP, highlights the importance of early discussions about fertility preservation, referral pathways, and addressing socioeconomic challenges in cancer care, emphasizing the role of Miami Cancer Institute's onco-fertility program.

A review of 5 studies reveals a significant 1 in 4 incidence of adverse maternal outcomes following uterine conservation in patients with placenta accreta spectrum, underlining the importance of expert multidisciplinary care.